Cargando…

IL-1 blockade as a novel approach to treatment of hyperzincemia and hypercalprotectinemia, a possible new autoinflammatory syndrome

Detalles Bibliográficos
Autores principales:	Lionetti, Geraldina, Bernstein, Jonathan A, Holzinger, Dirk, Jeng, Michael, Roth, Johannes, Zadeh, Neda, Hsu, Joyce
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3403091/ http://dx.doi.org/10.1186/1546-0096-10-S1-A87

Ejemplares similares

Extensive pyoderma gangrenosum-like lesions revealing a case of hyperzincemia and hypercalprotectinemia: when to suspect it?()()
por: Resende, Ludimila Oliveira, et al.
Publicado: (2019)

8. An autoinflammatory syndrome resembling Castleman’s disease with excellent response to IL-6 blockade
por: Chakravorty, Mithun, et al.
Publicado: (2019)

Idiopathic hyperzincemia with associated copper deficiency anemia: a diagnostic dilemma
por: Merza, Hussein, et al.
Publicado: (2015)

Copper deficiency-associated myelopathy in cryptogenic hyperzincemia: a case report
por: Mutti, Carlotta, et al.
Publicado: (2021)

A novel mutatioin in the PSTPIP1 gene is associated with an autoinflammatory disease distinct from classical PAPA syndrome
por: Holzinger, D, et al.
Publicado: (2011)

The role of S100 proteins in the pathogenesis and monitoring of autoinflammatory diseases
por: Holzinger, Dirk, et al.
Publicado: (2018)

Schnitzler syndrome, a rare autoinflammatory disease. Complete response to IL-1 blockade
por: Faggioli, Paola, et al.
Publicado: (2017)

The Central Role of Anti-IL-1 Blockade in the Treatment of Monogenic and Multi-Factorial Autoinflammatory Diseases
por: Federici, Silvia, et al.
Publicado: (2013)

Role of IL-1b in NLRP12-associated autoinflammatory disorders and resistance to anti-IL-1 therapy
por: Jeru, Isabelle, et al.
Publicado: (2011)

Recurrent Inflammatory Panniculitis with Partial Lipoatrophy and Elevated temperature: a possible new autoinflammatory disorder
por: Torrelo, A, et al.
Publicado: (2015)

Recommendations for the management of autoinflammatory diseases
por: ter Haar, N, et al.
Publicado: (2015)

Serum IL-18 is a specific biomarker for Macrophage Activation Syndrome across several autoinflammatory diseases
por: Canna, SW, et al.
Publicado: (2015)

IL-1 inhibition in autoinflammatory diseases
por: Martini, Alberto
Publicado: (2012)

Diversity in clinical manifestations of autoinflammatory syndromes
por: Boiu, S, et al.
Publicado: (2011)

Therapy of autoinflammatory diseases: a review of the literature
por: ter Haar, NM, et al.
Publicado: (2011)

Canakinumab for the treatment of different refractory autoinflammatory disorders
por: Grein, Ingrid HR, et al.
Publicado: (2014)

Development of the autoinflammatory disease damage index (ADDI)
por: Annink, K, et al.
Publicado: (2015)

NGS for the diagnosis of autoinflammatory diseases: the experience of Montpellier
por: Sarrabay, G, et al.
Publicado: (2015)

Familial Mediterranean Fever and Human autoinflammatory diseases
por: Hovhannisyan, L
Publicado: (2015)

Infectious adverse effects during treatment with IL-1 inhibitors in patients with systemic juvenile idiopathic arthritis and autoinflammatory diseases
por: Fernandez-Silveira, Laura, et al.
Publicado: (2014)

Autoinflammatory diseases: a possible cause of thrombosis?
por: La Regina, Micaela, et al.
Publicado: (2015)

Interleukin-1 Blockade in Polygenic Autoinflammatory Disorders: Where Are We now?
por: Malcova, Hana, et al.
Publicado: (2021)

Therapy of autoinflammatory diseases: results from an international registry
por: ter Haar, NM, et al.
Publicado: (2011)

PReS-FINAL-2210: Qualitative aspects of autoinflammatory diseases
por: Konukbay, D, et al.
Publicado: (2013)

NLRP12- associated autoinflammatory disorder: case report
por: Volpe, Giuseppina, et al.
Publicado: (2014)

NLRP1 mutations cause autoinflammatory diseases in human
por: Grandemange, S, et al.
Publicado: (2015)

Clinical experiences with canakinumab as a treatment for autoinflammatory disorders
por: Saperia, C, et al.
Publicado: (2015)

Stratification of patients with autoinflammatory phenotypes by interferon (IFN) score suggests a new group of IFN mediated autoinflammatory diseases with overlapping clinical phenotypes
por: de Jesus, A Almeida, et al.
Publicado: (2015)

Unexplained recurrent arthritis as presenting sign of hereditary autoinflammatory syndromes
por: Zulian, F, et al.
Publicado: (2011)

PReS-FINAL-2329: Validation of the autoinflammatory activity index (AIDAI)
por: Piram, M, et al.
Publicado: (2013)

Pathological and immunological features of autoinflammatory syndrome associated with lymphedema (AISLE)
por: Gul, A, et al.
Publicado: (2015)

The Eurofever Registry for autoinflammatory diseases: results of the first 15 months of enrolment
por: Toplak, N, et al.
Publicado: (2011)

Development and validation of juvenile autoinflammatory disease multidimensional assessment report (JAIMAR)
por: Konukbay, Dilek, et al.
Publicado: (2014)

Altered cytokine pattern and inflammatory pathways in monogenic and complex autoinflammatory diseases
por: Galozzi, P, et al.
Publicado: (2015)

Determinants of health-related quality of life in children and adults with autoinflammatory diseases
por: Erbis, G, et al.
Publicado: (2015)

Development and validation of juvenile autoinflammatory disease multidimensional assessment report (JAIMAR)
por: Konukbay, D, et al.
Publicado: (2015)

Interleukin-1-related cytokines as potential biomarkers in autoinflammatory skin diseases
por: Bonnekoh, H, et al.
Publicado: (2015)

Studying patients with autoinflammatory diseases: the past, present, and a perspective for the future
por: Hausmann, JS, et al.
Publicado: (2015)

Management of Monogenic IL-1 Mediated Autoinflammatory Diseases in Childhood
por: Welzel, Tatjana, et al.
Publicado: (2021)

IL-1 and autoinflammatory disease: biology, pathogenesis and therapeutic targeting
por: Broderick, Lori, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_096gcmd4cmik36e96hee9jsniq